Gene Editing
The latest news about Gene Editing: headlines, AI summaries and the full story from every source.
- Beam Therapeutics Shares Fall Despite Positive Risto-cel Clinical Trial Results
- Pomerantz Law Firm Investigates Cellectis S.A. Following Strategic Pivot and Stock Decline
- Gene Editing Stocks Drop Following Anthropic's AI Discovery
- Guggenheim Upgrades Editas Medicine Stock to Buy
- Vylor and Rainbow Crops Partner for Gene-Edited Corn Traits Using AI
- Cellectis Exits Two CAR-T Programs, Shifts Focus to Gene Editing for Lipid Disorders
- Scribe Therapeutics raises $129M in its gene editing IPO
- Cathie Wood Invests $362 Million in CRISPR Therapeutics Amid Promising R&D Developments
- Cibus Welcomes EU Decision on Non-Transgenic Crop Breeding
- Intellia Therapeutics' Crispr-based treatment shows success in pivotal trial for hereditary angioedema